Cargando…

The blunted effect of glucose-dependent insulinotropic polypeptide in subcutaneous abdominal adipose tissue in obese subjects is partly reversed by weight loss

BACKGROUND: Glucose-dependent insulinotropic polypeptide (GIP) appears to have impaired effect on subcutaneous abdominal adipose tissue metabolism in obese subjects. The aim of the present study was to examine whether weight loss may reverse the impaired effect of GIP on subcutaneous abdominal adipo...

Descripción completa

Detalles Bibliográficos
Autores principales: Asmar, M, Arngrim, N, Simonsen, L, Asmar, A, Nordby, P, Holst, J J, Bülow, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895376/
https://www.ncbi.nlm.nih.gov/pubmed/27136446
http://dx.doi.org/10.1038/nutd.2016.15
_version_ 1782435834482393088
author Asmar, M
Arngrim, N
Simonsen, L
Asmar, A
Nordby, P
Holst, J J
Bülow, J
author_facet Asmar, M
Arngrim, N
Simonsen, L
Asmar, A
Nordby, P
Holst, J J
Bülow, J
author_sort Asmar, M
collection PubMed
description BACKGROUND: Glucose-dependent insulinotropic polypeptide (GIP) appears to have impaired effect on subcutaneous abdominal adipose tissue metabolism in obese subjects. The aim of the present study was to examine whether weight loss may reverse the impaired effect of GIP on subcutaneous abdominal adipose tissue in obese subjects. METHODS: Five obese males participated in a 12-week weight loss program, which consisted of caloric restriction (800 Cal day(−)(1)) followed by 4 weeks of weight-maintenance diet. Before and after weight loss, subcutaneous adipose tissue lipid metabolism was studied by conducting regional measurements of arterio-venous plasma concentrations of metabolites and blood flow (adipose tissue blood flow, ATBF) across a segment of the abdominal adipose tissue in the fasting state and during GIP infusion (1.5 pmol kg(−)(1 )min(−)(1)) in combination with a hyperinsulinemic–hyperglycemic clamp. RESULTS: After weight loss (7.5±0.8 kg), glucose tolerance and insulin sensitivity increased significantly as expected. No significant differences were seen in basal ATBF before (1.3±0.4 ml min(−1) 100 g tissue(−1)) and after weight loss (2.1±0.4 ml min(−1) 100 g tissue)(−1); however, a tendency to increase was seen. After weight loss, GIP infusion increased ATBF significantly (3.2±0.1 ml min(−1) 100 g tissue(−1)) whereas there was no increase before weight loss. Triacylglycerol (TAG) uptake did not change after weight loss. Baseline free fatty acid (FFA) and glycerol output increased significantly after weight loss, P<0.001. During the clamp period, FFA and glycerol output declined significantly, P<0.05, with no differences before and after weight loss. Weight loss increased glucose uptake and decreased FFA/glycerol ratio during the clamp period, P<0.05. CONCLUSIONS: In obese subjects, weight loss, induced by calorie restriction, improves the blunted effect of GIP on subcutaneous abdominal adipose tissue metabolism.
format Online
Article
Text
id pubmed-4895376
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-48953762016-06-07 The blunted effect of glucose-dependent insulinotropic polypeptide in subcutaneous abdominal adipose tissue in obese subjects is partly reversed by weight loss Asmar, M Arngrim, N Simonsen, L Asmar, A Nordby, P Holst, J J Bülow, J Nutr Diabetes Original Article BACKGROUND: Glucose-dependent insulinotropic polypeptide (GIP) appears to have impaired effect on subcutaneous abdominal adipose tissue metabolism in obese subjects. The aim of the present study was to examine whether weight loss may reverse the impaired effect of GIP on subcutaneous abdominal adipose tissue in obese subjects. METHODS: Five obese males participated in a 12-week weight loss program, which consisted of caloric restriction (800 Cal day(−)(1)) followed by 4 weeks of weight-maintenance diet. Before and after weight loss, subcutaneous adipose tissue lipid metabolism was studied by conducting regional measurements of arterio-venous plasma concentrations of metabolites and blood flow (adipose tissue blood flow, ATBF) across a segment of the abdominal adipose tissue in the fasting state and during GIP infusion (1.5 pmol kg(−)(1 )min(−)(1)) in combination with a hyperinsulinemic–hyperglycemic clamp. RESULTS: After weight loss (7.5±0.8 kg), glucose tolerance and insulin sensitivity increased significantly as expected. No significant differences were seen in basal ATBF before (1.3±0.4 ml min(−1) 100 g tissue(−1)) and after weight loss (2.1±0.4 ml min(−1) 100 g tissue)(−1); however, a tendency to increase was seen. After weight loss, GIP infusion increased ATBF significantly (3.2±0.1 ml min(−1) 100 g tissue(−1)) whereas there was no increase before weight loss. Triacylglycerol (TAG) uptake did not change after weight loss. Baseline free fatty acid (FFA) and glycerol output increased significantly after weight loss, P<0.001. During the clamp period, FFA and glycerol output declined significantly, P<0.05, with no differences before and after weight loss. Weight loss increased glucose uptake and decreased FFA/glycerol ratio during the clamp period, P<0.05. CONCLUSIONS: In obese subjects, weight loss, induced by calorie restriction, improves the blunted effect of GIP on subcutaneous abdominal adipose tissue metabolism. Nature Publishing Group 2016-05 2016-05-02 /pmc/articles/PMC4895376/ /pubmed/27136446 http://dx.doi.org/10.1038/nutd.2016.15 Text en Copyright © 2016 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Original Article
Asmar, M
Arngrim, N
Simonsen, L
Asmar, A
Nordby, P
Holst, J J
Bülow, J
The blunted effect of glucose-dependent insulinotropic polypeptide in subcutaneous abdominal adipose tissue in obese subjects is partly reversed by weight loss
title The blunted effect of glucose-dependent insulinotropic polypeptide in subcutaneous abdominal adipose tissue in obese subjects is partly reversed by weight loss
title_full The blunted effect of glucose-dependent insulinotropic polypeptide in subcutaneous abdominal adipose tissue in obese subjects is partly reversed by weight loss
title_fullStr The blunted effect of glucose-dependent insulinotropic polypeptide in subcutaneous abdominal adipose tissue in obese subjects is partly reversed by weight loss
title_full_unstemmed The blunted effect of glucose-dependent insulinotropic polypeptide in subcutaneous abdominal adipose tissue in obese subjects is partly reversed by weight loss
title_short The blunted effect of glucose-dependent insulinotropic polypeptide in subcutaneous abdominal adipose tissue in obese subjects is partly reversed by weight loss
title_sort blunted effect of glucose-dependent insulinotropic polypeptide in subcutaneous abdominal adipose tissue in obese subjects is partly reversed by weight loss
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895376/
https://www.ncbi.nlm.nih.gov/pubmed/27136446
http://dx.doi.org/10.1038/nutd.2016.15
work_keys_str_mv AT asmarm thebluntedeffectofglucosedependentinsulinotropicpolypeptideinsubcutaneousabdominaladiposetissueinobesesubjectsispartlyreversedbyweightloss
AT arngrimn thebluntedeffectofglucosedependentinsulinotropicpolypeptideinsubcutaneousabdominaladiposetissueinobesesubjectsispartlyreversedbyweightloss
AT simonsenl thebluntedeffectofglucosedependentinsulinotropicpolypeptideinsubcutaneousabdominaladiposetissueinobesesubjectsispartlyreversedbyweightloss
AT asmara thebluntedeffectofglucosedependentinsulinotropicpolypeptideinsubcutaneousabdominaladiposetissueinobesesubjectsispartlyreversedbyweightloss
AT nordbyp thebluntedeffectofglucosedependentinsulinotropicpolypeptideinsubcutaneousabdominaladiposetissueinobesesubjectsispartlyreversedbyweightloss
AT holstjj thebluntedeffectofglucosedependentinsulinotropicpolypeptideinsubcutaneousabdominaladiposetissueinobesesubjectsispartlyreversedbyweightloss
AT bulowj thebluntedeffectofglucosedependentinsulinotropicpolypeptideinsubcutaneousabdominaladiposetissueinobesesubjectsispartlyreversedbyweightloss
AT asmarm bluntedeffectofglucosedependentinsulinotropicpolypeptideinsubcutaneousabdominaladiposetissueinobesesubjectsispartlyreversedbyweightloss
AT arngrimn bluntedeffectofglucosedependentinsulinotropicpolypeptideinsubcutaneousabdominaladiposetissueinobesesubjectsispartlyreversedbyweightloss
AT simonsenl bluntedeffectofglucosedependentinsulinotropicpolypeptideinsubcutaneousabdominaladiposetissueinobesesubjectsispartlyreversedbyweightloss
AT asmara bluntedeffectofglucosedependentinsulinotropicpolypeptideinsubcutaneousabdominaladiposetissueinobesesubjectsispartlyreversedbyweightloss
AT nordbyp bluntedeffectofglucosedependentinsulinotropicpolypeptideinsubcutaneousabdominaladiposetissueinobesesubjectsispartlyreversedbyweightloss
AT holstjj bluntedeffectofglucosedependentinsulinotropicpolypeptideinsubcutaneousabdominaladiposetissueinobesesubjectsispartlyreversedbyweightloss
AT bulowj bluntedeffectofglucosedependentinsulinotropicpolypeptideinsubcutaneousabdominaladiposetissueinobesesubjectsispartlyreversedbyweightloss